The MD Anderson Cancer Center Prostate SPORE Developmental Research Program provides initial funding for promising pilot translational research studies in prostate cancer. This Program emphasizes support for translational research projects that can generate clinically testable hypotheses to help reduce the incidence and mortality of prostate cancer or to improve the quality of life for patients with prostate cancer. Both clinical and laboratory research projects are eligible for funding.
Each Developmental Research Program project award may be a maximum of $50,000 plus overhead per year. Funding is for one year but can be renewed for one additional year.
- Candidates must have an M.D. and/or Ph.D. degree.
- Candidates from inside and outside the SPORE community may apply.
- Program projects must align with the focus of the MD Anderson Cancer Center Prostate SPORE.
- Program projects must reflect translational research in prostate cancer aimed at generating clinically testable hypotheses for reducing the incidence and mortality of prostate cancer or improving the quality of life for patients with the disease.
Timothy C. Thompson, Ph.D.
Director, Developmental Research Program
Elsa M. Perezous
Grant Program Manager
Sandra A. Remenda
Grant Program Coordinator